medical implant News
-
Buy-out of the Helioscopie company by the Santé Actions group
On October 26, 2010, Helioscopie, an expert company in medical implants in the obesity field located in Vienne, France (38), came under new direction. The Santé Actions group took control of the company. Dr. Sauveur Ferrara will hold the office of President. Dr. Ferrara, the President and founder of the Santé Actions group, a company specialized in health and medico-social care, is ...
-
Faster Learning Beats Better Planning
The ability to make things, if only to quickly turn around and break them, is useful when advancing an idea or design. It’s common now for design teams to have a 3D printer at their disposal for mocking things up and sometimes even building useful stuff. With all the excitement about additive manufacturing, though, its easy to overlook advancements that have been made with CNC equipment. ...
By Echobio, LLC
-
Digital Image Correlation for Medical Implants
Too many measurements aren't made because they are difficult to make or inaccurate when made under live, realistic conditions. Digital Image Correlation (DIC) changes that and offers an efficient, non-contact way to measure motion and strain in real time. Use DIC as a non-contacting extensometer on flat or curved surfaces including wires during stress-strain tests. Identify stress concentrations ...
By Echobio, LLC
-
Lattice Medical announces the closing of a €8 million Series A financing round
LATTICE MEDICAL, announces the closing of a second round of financing of 8 million euros. This round was led by the historical funds Finovam Gestion, Nord France Amorçage and WiSEED alongside the Captech Santé fund. The European Commission, via its EIC Fund, and Santelys are co-investing. The financing round is completed by non-dilutive financing, in the form of a grant and debt ...
-
Second Patent Issued for Healionics’ Textured STAR Biointerface
Healionics Corporation has received a further patent for its textured STAR Biointerface technology. The United States Patent and Trademark Office issued Patent No. 8,647,393, "Implantable Medical Devices Having Microporous Surface Layers and Method for Reducing Foreign Body Response to the Same.” This new patent extends the scope of 8,372,423 issued to Healionics in February 2013. The STAR ...
By Healionics
-
Nanovis Wins the Global Health & Pharma 2018 Technology Awards
CARMEL, Indiana. – Sept. 11, 2018 – Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores. This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell binding and ...
By Nanovis
-
Bruker Appoints Robert Rosenthal to Board of Directors
Bruker Corporation (NASDAQ:BRKR) today announced that it has appointed Dr. Robert Rosenthal to its Board of Directors, effective immediately. Dr. Rosenthal currently serves as Chief Executive Officer and as a director for Taconic Biosciences, Inc., a privately-held provider of research models for the pharmaceutical and biotech industry, a position he has held since joining Taconic Biosciences in ...
-
Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus
Surgeons at Intermountain Primary Children’s Hospital are the first in the nation to successfully implant a new brain shunt accessory for young patients with hydrocephalus, a neurological condition that causes a buildup of cerebrospinal fluid in the deep cavities of the brain that often causes frequent hospitalizations. This extra fluid puts pressure on the brain and can cause brain ...
-
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference. A Pre-recorded presentation will be available on Monday, January 10th ...
-
Avery Biomedical Letter to Medscape Regarding Diaphragm Pacing
Please find below a letter that our attorney sent to the editors of Medscape (parent company WebMD) who have published false information about our product. Medscape Letter Regarding Avery System Avery Biomedical Devices has an outstanding track record spanning over 45 years including an outstanding safety record, long term viability with some patients pacing for more than 35 years, and ...
-
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming 42nd Annual Cowen Health Care Conference. Date: Wednesday, March 9, 2022 Format: Fireside chat and 1×1 meetings The ...
-
Field Orthopaedics announces strategic alliance with Medartis Inc
The strategic alliance will see the NX Nail system from Field Orthopaedics added to Medartis’ comprehensive hand portfolio in an exclusive distribution partnership, which will extend the global distribution footprint of the product and provide growth opportunities in international markets. With an anatomically inspired head, narrow waist and cutting efficiency, the NX Nail is engineered to ...
-
Healionics Awarded SBIR Contract from DOD to Develop Biointegrated Synthetic Vascular Graft
Healionics Corporation has been awarded a $150,000 Small Business Innovation Research (SBIR) contract from the Department of Defense (DOD) to demonstrate feasibility for an improved vascular graft design. Andrew Marshall, PhD, Healionics’ Chief Technology Officer, is the Principal Investigator for this research project. Titled, “Biointegrated Synthetic Grafts for Vascular ...
By Healionics
-
Biomedical Catalyst Grant Award to Arterius Limited
Following the successful completion of the R&D project in 30th September 2016 (supported by a Smart award from the Innovate UK (TSB), Arterius has recently been awarded further funding from the Biomedical Catalyst-Early Stage programme to conduct the In-vitro and In-vivo GLP Evaluation of the Novel Bioresorbable Coronary Scaffolds; ArterioSorb. ArterioSorb is an innovative medical implant ...
-
ASTM F1582 - 98(2011) Standard Terminology Relating to Spinal Implants
1. Scope 1.1 This terminology covers basic terms and considerations for spinal implant devices and their mechanical analyses. 2. Referenced Documents (purchase separately) ASTM Standards E6 Terminology Relating to Methods of Mechanical Testing E1150 Definitions of Terms Relating to Fatigue Index Terms 0 Spinal implants; Terminology--medical/surgical systems/applications ICS ...
-
Neuspera Announces Second Phase of Sans-UUI IDE Clinical Trial with Nuvella System
Neuspera Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced it will begin enrollment in its pivotal clinical trial (SANS-UUI), a single-arm study that will enroll 145 patients at 25 sites globally. The study will evaluate the safety and efficacy of Neuspera’s Nuvella™ system designed to treat overactive bladder ...
-
Healionics Awarded $1.7M SBIR Grant from NIH to Advance New Vascular Graft Toward First-In-Human Use
Healionics Corporation, a Seattle-based medical device company, has received notice from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of a $1.7M Fast-Track Small Business Innovation Research (SBIR) grant in support of regulatory approval and a clinical study of STARgraftTM, its innovative synthetic vascular graft. Andrew Marshall, Healionics’ Chief Technology ...
By Healionics
-
Neuspera Announces Leadership Expansion with the Addition of New CFO and CMO
Neuspera Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of industry veterans Melissa Farina as Chief Financial Officer and Steven Siegel, MD, as Chief Medical Officer. Farina and Siegel have joined Neuspera as the company recently began enrollment of the second phase of their pivotal clinical ...
-
Silver Bullet Therapeutics Announces Allowance of Two New Patents and Commercial Availability of the OrthoFuzIon Antimicrobial Bone Screw System
Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office allowed two new patents that include, COATINGS FOR THE CONTROLLABLE RELEASE OF ANTIMICROBIAL METAL IONS and BONE IMPLANT AND SYSTEMS THAT CONTROLLABLY RELEASES SILVER. The Company also announced that they will make the OrthoFuzIon Antimicrobial Bone Screw System ...
-
Plastics Healthcare Market Watch Highlights Plastics Growing Role in Medicine
In a Plastics Market Watch report released today, Watching: Plastics’ Contribution to Healthcare, The Plastics Industry Association (PLASTICS) reported a growing demand for plastics in a number of healthcare sectors including pharmaceuticals, surgical equipment and tools, vision/dental/hearing, research labs and more. According to the report, medical equipment and supplies production ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you